Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
Cancers|July 29, 2025
CD34+ Cell Dose, Measurable Residual Disease, and Outcome After Myeloablative HLA-Matched Peripheral Blood Hematopoietic Cell Transplantation for Adults with Acute Myeloid LeukemiaMargery Gang, Megan Othus, Anne-Chloe Olix, et al.Blood|December 22, 2005
Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemiaDerek L Stirewalt, Kenneth J Kopecky, Soheil Meshinchi, et al.Blood|February 29, 2008
Structural and numerical variation of FLT3/ITD in pediatric AMLSoheil Meshinchi, Derek L Stirewalt, Todd A Alonzo, et al.Transplantation and Cellular Therapy|December 26, 2024
Pretransplant Chromosome Genomic Array Testing Improves Prognostication for Myelofibrosis Patients Undergoing TransplantationXiaoyu Qu, Emily Stevens, Matthew P Fitzgibbon, et al.Plos One|September 24, 2015
Transcriptome Profiling of Pediatric Core Binding Factor AMLChih-Hao Hsu, Cu Nguyen, Chunhua Yan, et al.Blood|October 18, 2008
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemiaPamela S Becker, Kenneth J Kopecky, Adrianne N Wilks, et al.Blood|August 17, 2006
Clinical implications of FLT3 mutations in pediatric AMLSoheil Meshinchi, Todd A Alonzo, Derek L Stirewalt, et al.Blood|December 16, 2006
Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemiaOlga Sala-Torra, Holly M Gundacker, Derek L Stirewalt, et al.Transplantation and Cellular Therapy|July 21, 2026
Significance of CD34+ Cell Dose on Outcomes of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation in AML: An Analysis Stratified by MRD StatusMargery Gang, Megan Othus, Anne-Chloe Olix, et al.Journal of Proteome Research|August 21, 2012
Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data setsEric J Foss, Dragan Radulovic, Derek L Stirewalt, et al.Pageof 7